(March 12, 2024, 1:58 PM EDT) -- LONDON — A justice of the High Court of England Wales issued a ruling barring some objections and dismissing in part challenges the Czech Republic seeks to bring in a forthcoming trial in which it is challenging a May 2022 arbitral award ordering it to pay a Liechtenstein company and its former owner $350 million for harming their investment in a blood plasma company in the early 1990s (Czech Republic v. Diag Human SE, et al., No. CL-2022-000307CA, [2024] EWHC 503 (Comm), England and Wales High, KBD)....